Promising vaccine could treat two deadliest and fastest-rising forms of cancer, early study shows
A phase 1, first-in-human trial showed that an off-the-shelf vaccine lowered the risk of relapse in patients with colon and pancreatic cancer. It does this by attacking the KRAS mutation in the cancers.
Mail Online - Haberin Alındığı Kaynak URL
Önemli Not: Bu haberlerin hukuki muhatabı haber kaynaklarıdır. Haberlerle ilgili her tür şikayetinizi adresimize gönderebilirsiniz.
